And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

SURF Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 12.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $28,245.12

Surface Oncology Insider Trading History Chart

Surface Oncology Share Price & Price History

^$1.07

▼ -0.01 (-0.93%)

As of 09/8/2023 09:00 PM ET

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

Surface Oncology Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/1/2023	Chandra Adams	Insider	Sell	3,901	$0.94	$3,666.94	30,899
8/1/2023	Jessica Fees	CFO	Sell	9,434	$0.94	$8,867.96	101,915
8/1/2023	Robert W Ross	CEO	Sell	16,713	$0.94	$15,710.22	83,193
8/3/2022	Henry C Rath	Insider	Sell	5,676	$1.72	$9,762.72	32,324
8/3/2022	Jessica Fees	CFO	Sell	5,980	$1.72	$10,285.60	111,349
8/3/2022	Robert W Ross	CEO	Sell	10,594	$1.72	$18,221.68	99,906
6/10/2021	Jeff Goater	Director	Sell	234,727	$7.66	$1,798,008.82	462,000

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

SEC Filings (Institutional Ownership Changes) for Surface Oncology (NASDAQ:SURF)

37.21% of Surface Oncology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Surface Oncology Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/15/2023	Boothbay Fund Management LLC	45,000	$39K	0.0%	N/A	0.074%
8/15/2023	Black Maple Capital Management LP	266,736	$0.23M	0.1%	N/A	0.439%
8/11/2023	Renaissance Technologies LLC	567,400	$0.49M	0.0%	-10.6%	0.933%
8/11/2023	BlackRock Inc.	520,886	$0.45M	0.0%	-24.6%	0.856%
8/11/2023	Geode Capital Management LLC	667,418	$0.58M	0.0%	+69.3%	1.097%
8/10/2023	Charles Schwab Investment Management Inc.	44,721	$39K	0.0%	N/A	0.074%
8/10/2023	Citigroup Inc.	37,657	$33K	0.0%	-96.4%	0.062%
8/7/2023	Acadian Asset Management LLC	868,620	$0.75M	0.0%	-17.4%	1.428%
7/10/2023	ARK Investment Management LLC	1,412,077	$1.23M	0.0%	-74.3%	2.326%
5/22/2023	Arete Wealth Advisors LLC	53,965	$38K	0.0%	N/A	0.089%
5/16/2023	Jane Street Group LLC	51,083	$36K	0.0%	-61.2%	0.084%
5/15/2023	EcoR1 Capital LLC	3,082,959	$2.15M	0.1%	-21.4%	5.078%
5/15/2023	Two Sigma Investments LP	47,410	$33K	0.0%	+81.2%	0.078%
5/15/2023	XTX Topco Ltd	37,874	$26K	0.0%	-79.4%	0.062%
5/12/2023	Renaissance Technologies LLC	635,000	$0.44M	0.0%	-11.1%	1.046%
5/12/2023	Stifel Financial Corp	387,625	$0.27M	0.0%	-7.6%	0.638%
5/12/2023	Prudential Financial Inc.	39,000	$27K	0.0%	+248.2%	0.064%
5/12/2023	Dimensional Fund Advisors LP	95,083	$66K	0.0%	-52.9%	0.157%
5/11/2023	Acadian Asset Management LLC	1,051,718	$0.73M	0.0%	-3.7%	1.732%
5/3/2023	Nikko Asset Management Americas Inc.	999,026	$0.65M	0.0%	-6.8%	1.645%
5/1/2023	Arete Wealth Advisors LLC	53,965	$37.71B	0.0%	N/A	0.089%
4/27/2023	Sumitomo Mitsui Trust Holdings Inc.	999,026	$0.70M	0.0%	-6.8%	1.645%
4/17/2023	ARK Investment Management LLC	5,496,146	$3.84M	0.0%	-1.3%	9.052%
2/15/2023	Jane Street Group LLC	131,569	$0.11M	0.0%	N/A	0.217%
2/15/2023	Tang Capital Management LLC	429,647	$0.35M	0.1%	N/A	0.710%
2/15/2023	Millennium Management LLC	415,270	$0.34M	0.0%	+11.2%	0.686%
2/15/2023	Morgan Stanley	47,781	$39K	0.0%	-38.7%	0.079%
2/15/2023	Man Group plc	38,864	$32K	0.0%	+190.0%	0.064%
2/14/2023	Susquehanna International Group LLP	49,815	$41K	0.0%	+108.3%	0.082%
2/14/2023	Marshall Wace LLP	110,928	$91K	0.0%	-46.4%	0.183%
2/13/2023	Nikko Asset Management Americas Inc.	1,072,013	$0.86M	0.0%	-2.9%	1.771%
2/13/2023	Barclays PLC	107,317	$88K	0.0%	-74.3%	0.177%
2/13/2023	Renaissance Technologies LLC	714,155	$0.59M	0.0%	-27.5%	1.180%
2/13/2023	Geode Capital Management LLC	386,312	$0.32M	0.0%	+3.7%	0.638%
2/13/2023	GSA Capital Partners LLP	276,403	$0.23M	0.0%	+129.6%	0.457%
1/30/2023	Sumitomo Mitsui Trust Holdings Inc.	1,072,013	$0.88M	0.0%	-2.9%	1.771%
1/30/2023	International Assets Investment Management LLC	48,830	$40K	0.0%	+28.7%	0.081%
1/25/2023	Eagle Rock Investment Company LLC	42,000	$41K	0.0%	+90.9%	0.069%
1/24/2023	International Assets Investment Management LLC	76,830	$50K	0.0%	+102.5%	0.127%
1/24/2023	ARK Investment Management LLC	5,567,224	$4.57M	0.0%	-7.8%	9.196%
11/15/2022	Two Sigma Advisers LP	44,500	$46K	0.0%	+36.5%	0.074%
11/15/2022	Two Sigma Investments LP	154,795	$0.16M	0.0%	-13.6%	0.256%
11/15/2022	Vanguard Group Inc.	2,308,470	$2.40M	0.0%	+28.2%	3.813%
11/15/2022	Marshall Wace LLP	206,953	$0.22M	0.0%	+81.2%	0.342%
11/15/2022	EcoR1 Capital LLC	3,924,713	$4.08M	0.1%	-15.7%	6.483%
11/14/2022	Royal Bank of Canada	146,340	$0.15M	0.0%	+10.4%	0.242%
11/14/2022	Renaissance Technologies LLC	985,343	$1.03M	0.0%	+19.6%	1.628%
11/14/2022	Forefront Analytics LLC	66,838	$70K	0.0%	+60.3%	0.110%
11/10/2022	Kingsbury Capital Investment Advisors LLC	144,217	$0.15M	0.2%	+69.3%	0.238%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	98,062	$0.10M	0.0%	N/A	0.162%
11/10/2022	Dimensional Fund Advisors LP	202,064	$0.21M	0.0%	-68.0%	0.334%
11/10/2022	Tower Research Capital LLC TRC	37,300	$39K	0.0%	+646.9%	0.062%
11/10/2022	UBS Group AG	62,127	$65K	0.0%	-65.6%	0.103%
11/3/2022	Barclays PLC	417,765	$0.43M	0.0%	-3.0%	0.720%
10/21/2022	Sumitomo Mitsui Trust Holdings Inc.	1,104,230	$1.15M	0.0%	N/A	1.903%
10/17/2022	ARK Investment Management LLC	6,035,691	$6.28M	0.0%	+8.6%	10.400%
8/18/2022	Goldman Sachs Group Inc.	1,069,911	$1.76M	0.0%	+25.2%	1.844%
8/16/2022	DAFNA Capital Management LLC	1,100,000	$1.80M	0.5%	+61.8%	1.896%
8/15/2022	AQR Capital Management LLC	49,606	$81K	0.0%	-89.0%	0.085%
8/15/2022	State Street Corp	171,566	$0.28M	0.0%	-70.7%	0.296%
8/15/2022	Cubist Systematic Strategies LLC	27,235	$45K	0.0%	+144.3%	0.047%
8/15/2022	Laurion Capital Management LP	665,400	$1.09M	0.0%	N/A	1.147%
8/15/2022	Millennium Management LLC	700,787	$1.15M	0.0%	N/A	1.208%
8/13/2022	Renaissance Technologies LLC	823,690	$1.35M	0.0%	+37.6%	1.419%
8/12/2022	Northern Trust Corp	55,155	$90K	0.0%	-81.4%	0.095%
8/12/2022	FMR LLC	375,226	$0.62M	0.0%	-52.9%	0.647%
8/12/2022	BNP Paribas Arbitrage SA	16,846	$28K	0.0%	+440.1%	0.029%
8/12/2022	Franklin Resources Inc.	56,647	$93K	0.0%	N/A	0.098%
8/11/2022	UBS Group AG	180,682	$0.30M	0.0%	+124.6%	0.311%
8/10/2022	Forefront Analytics LLC	41,688	$71K	0.0%	+111.5%	0.072%
8/9/2022	Kingsbury Capital Investment Advisors LLC	85,166	$0.14M	0.2%	+171.3%	0.147%
8/8/2022	Keybank National Association OH	26,455	$43K	0.0%	N/A	0.048%
8/5/2022	Los Angeles Capital Management LLC	32,663	$54K	0.0%	-83.7%	0.060%
7/11/2022	ARK Investment Management LLC	5,557,382	$10.28M	0.1%	+4.0%	10.176%
6/7/2022	Bank of America Corp DE	17,361	$51K	0.0%	-82.5%	0.032%
5/17/2022	Virtu Financial LLC	27,194	$80K	0.0%	N/A	0.050%
5/17/2022	Royal Bank of Canada	119,929	$0.35M	0.0%	+7.7%	0.220%
5/17/2022	Delphia USA Inc.	12,075	$36K	0.0%	N/A	0.022%
5/16/2022	Goldman Sachs Group Inc.	854,599	$2.51M	0.0%	+19.8%	1.565%
5/16/2022	PDT Partners LLC	90,431	$0.27M	0.0%	-13.4%	0.166%
5/16/2022	State Street Corp	585,400	$1.72M	0.0%	+1.6%	1.072%
5/13/2022	Renaissance Technologies LLC	598,628	$1.76M	0.0%	N/A	1.096%
5/13/2022	Northern Trust Corp	297,099	$0.87M	0.0%	-4.5%	0.544%
5/13/2022	Charles Schwab Investment Management Inc.	94,404	$0.28M	0.0%	+7.3%	0.173%
5/13/2022	Prudential Financial Inc.	490,135	$1.44M	0.0%	+87.8%	0.898%
5/13/2022	Parkman Healthcare Partners LLC	209,148	$0.62M	0.2%	-19.2%	0.383%
5/13/2022	Vanguard Group Inc.	1,521,003	$4.47M	0.0%	+4.2%	2.785%
5/13/2022	Dimensional Fund Advisors LP	742,962	$2.18M	0.0%	+83.5%	1.360%
5/12/2022	BlackRock Inc.	2,548,105	$7.49M	0.0%	-0.6%	4.666%
5/12/2022	Acadian Asset Management LLC	220,227	$0.65M	0.0%	+34.9%	0.403%
5/11/2022	JPMorgan Chase & Co.	22,082	$65K	0.0%	+26.4%	0.040%
5/11/2022	GSA Capital Partners LLP	27,568	$81K	0.0%	N/A	0.050%
5/9/2022	Principal Financial Group Inc.	44,105	$0.13M	0.0%	-31.3%	0.081%
5/9/2022	Forefront Analytics LLC	19,713	$62K	0.0%	N/A	0.036%
5/6/2022	Los Angeles Capital Management LLC	199,825	$0.59M	0.0%	+104.0%	0.366%
5/6/2022	Princeton Global Asset Management LLC	53,442	$0.16M	0.0%	N/A	0.098%
5/5/2022	Russell Investments Group Ltd.	9,240	$27K	0.0%	N/A	0.017%
5/4/2022	SummerHaven Investment Management LLC	134,167	$0.39M	0.2%	+4.8%	0.246%
5/4/2022	Formidable Asset Management LLC	11,150	$33K	0.0%	N/A	0.020%
4/29/2022	SG Americas Securities LLC	10,043	$30K	0.0%	-33.4%	0.021%

Data available starting January 2016

Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibody that inhibits CD39 enzymatic activity for the production of adenosine and the breakdown of adenosine triphosphate; SRF388 which is in phase II clinical trial targeting interleukin 27; GSK4381562, an antibody targeting CD112R, an inhibitory protein expressed on natural killer and T cells; and SRF114 that is in phase 1/2 clinical trials targeting the chemokine receptor CCR8. Surface Oncology, Inc. has a license agreement with GlaxoSmithKline Intellectual Property (No. 4) Limited and Vaccinex, Inc. to develop, manufacture, and commercialize antibodies, which targets SRF114. The company was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. As of September 8, 2023, Surface Oncology, Inc. operates as a subsidiary of Coherus BioSciences, Inc.

Today's Range

Now: $1.07

$1.01

$1.09

50 Day Range

MA: $1.01

$0.88

$1.08

52 Week Range

Now: $1.07

$0.56

$1.43

Volume

1,510,100 shs

Average Volume

430,375 shs

Market Capitalization

$65.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.75

Who are the company insiders with the largest holdings of Surface Oncology?: Surface Oncology's top insider shareholders include:
Jessica Fees (CFO)
Robert W Ross (CEO)
Henry C Rath (Insider)
Chandra Adams (Insider)
Learn More about top insider investors at Surface Oncology.

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

>> Register right here